EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Nirsevimab for Prevention of RSV Hospitalizations in Infants

Saul N Faust, Simon B Drysdale, Natalya C Vassilouthis, HARMIONE Study Group

New England Journal of Medicine · 21.03.2024 · 390 (12) · 1152-1153

DOI: 10.1056/nejmc2400983 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 21.03.2024. Verfasst von Saul N Faust und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Southampton, Southampton, United Kingdom s.faust@soton.ac.uk. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Hospitalization. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedHospitalizationInfantHumans

Substanzen

nirsevimabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • University of Southampton, Southampton, United Kingdom s.faust@soton.ac.uk.
  • St. George's University Hospitals National Health Service Foundation Trust, London, United Kingdom.
  • Sanofi, Reading, United Kingdom.

Zitieren

APA

Faust, S. N., Drysdale, S. B., Vassilouthis, N. C., & HARMIONE Study Group (2024). Nirsevimab for Prevention of RSV Hospitalizations in Infants. New England Journal of Medicine, 390(12), 1152-1153. https://doi.org/10.1056/nejmc2400983

Vancouver

Faust SN, Drysdale SB, Vassilouthis NC, HARMIONE Study Group. Nirsevimab for Prevention of RSV Hospitalizations in Infants. New England Journal of Medicine. 2024;390(12):1152-1153. doi:10.1056/nejmc2400983

BibTeX
@article{Faust2024,
  author = {Faust, Saul N and Drysdale, Simon B and Vassilouthis, Natalya C and HARMIONE Study Group, HARMIONE Study Group},
  title = {Nirsevimab for Prevention of RSV Hospitalizations in Infants},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {12},
  pages = {1152--1153},
  doi = {10.1056/nejmc2400983}
}
Kostenlos starten →